OncoMatch/Clinical Trials/NCT06820164
Lipomas Treated with Subcutaneous Injections of Cooled Sodium Chloride
Is NCT06820164 recruiting? Yes, currently enrolling (May 2026). This Phase 1/2 trial studies Cooled Sodium Chloride for lipoma.
Treatment: Cooled Sodium Chloride — Lipomas are benign tumors composed of mature adipose tissue. While harmless, these are the most common type of soft tissue growths with some patients developing numerous lipomas. Patients often seek removal for cosmesis, or symptoms caused by location and/or compression of surrounding structures. This exploratory study aims to evaluate the effectiveness of subcutaneous injections of cooled normal saline as a treatment option for lipomas. The study will assess whether this technique could serve as a viable alternative to existing treatment options, especially compared to topically applied fat-freezing devices. The Investigators propose that this method may offer a more comfortable nonsurgical option for targeted fat reduction, as the cold temperatures are applied directly to the lipomas.
Check if I qualifyEligibility summary
For patients with Lipoma.
This summary was generated by AI from the trial's official eligibility criteria and may contain errors. Always confirm with the study team before contacting a site.
US trial sites
- West Virginia University · Morgantown, West Virginia
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify